{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:09:39Z","timestamp":1788826179952,"version":"build-2803163510"},"reference-count":42,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T00:00:00Z","timestamp":1774396800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100004622","name":"Dutch Cancer Society","doi-asserted-by":"publisher","award":["2016-10424"],"award-info":[{"award-number":["2016-10424"]}],"id":[{"id":"10.13039\/501100004622","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Few studies examined treatment-specific long-term risks of cardiovascular diseases (CVD) in diffuse large B-cell lymphoma survivors treated with potentially cardiotoxic radiotherapy and\/or chemotherapy with or without rituximab after the 1990s.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Long-term CVD risk was examined in a multicenter cohort comprising 2356 diffuse large B-cell lymphoma survivors who survived at least 5 years and who were treated at ages 15-61\u2009years in 1989-2012. CVD data were acquired from medical records, general practitioners, and disease registries. Observed CVD numbers were compared with expected CVD incidence in the Dutch population to estimate standardized incidence ratios (SIRs) and absolute excess risks (10\u200a000 person-years). Treatment-specific CVD risks were assessed using multivariable Cox regression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>During a median follow-up of 14.2\u2009years (IQR = 10.1-18.9 years), 312 survivors were diagnosed with a first CVD at least 5\u2009years after treatment. Compared with the general population, diffuse large B-cell lymphoma survivors had increased risks of heart failure ([HF]; SIR = 3.9, 95% confidence interval [CI] = 3.4 to 4.6; absolute excess risk = 62.8) and cerebrovascular accident (SIR = 1.3, 95% CI = 1.0 to 1.7; absolute excess risk = 9.8), while risk of coronary artery disease was decreased (SIR = 0.7, 95% CI = 0.5 to 0.9; absolute excess risk = \u221230.9). HF risk was higher among females (SIR = 5.3, 95% CI = 4.2 to 6.5) than males (SIR = 3.2, 95% CI = 2.6 to 4.0, P for heterogeneity &amp;lt; .001), and among survivors aged 40\u2009years and younger at diffuse large B-cell lymphoma treatment (SIR = 10.5, 95% CI = 7.2 to 14.8; P for trend &amp;lt; .001). Exposure to more than 300\u2009mg\/m2 doxorubicin was associated with a 2.8-fold (95% CI = 1.7 to 4.5) increased risk of cardiomyopathy or HF, while radiotherapy involving the heart was associated with a 1.9-fold (95% CI = 1.1 to 3.1) increased risk of valvular heart disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Those surviving at least 5 years after diffuse large B-cell lymphoma have increased risks of developing CVDs, especially HF. Physicians and patients should recognize this risk, and individualized cardiac screening should be considered.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/jnci\/djag085","type":"journal-article","created":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T12:42:36Z","timestamp":1773924156000},"page":"1628-1637","source":"Crossref","is-referenced-by-count":2,"title":["Cardiovascular disease risk after radiotherapy and anthracycline-based chemotherapy for diffuse large B-cell lymphoma"],"prefix":"10.1093","volume":"118","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9010-4919","authenticated-orcid":false,"given":"Yvonne M","family":"Geurts","sequence":"first","affiliation":[{"name":"Department of Epidemiology, Netherlands Cancer Institute , Amsterdam,","place":["the Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1678-4298","authenticated-orcid":false,"given":"Suzanne I M","family":"Neppelenbroek","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Netherlands Cancer Institute , Amsterdam,","place":["the Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2306-6590","authenticated-orcid":false,"given":"Berthe M P","family":"Aleman","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Netherlands Cancer Institute , Amsterdam,","place":["the Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3860-8698","authenticated-orcid":false,"given":"C\u00e9cile P M","family":"Janus","sequence":"additional","affiliation":[{"name":"Department of Radiotherapy, Erasmus Medical Centre , Rotterdam,","place":["the Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3257-3634","authenticated-orcid":false,"given":"Augustinus D G","family":"Krol","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Leiden University Medical Centre , Leiden,","place":["the Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dick Johan","family":"van Spronsen","sequence":"additional","affiliation":[{"name":"Department of Hematology, Radboud University Medical Centre , Nijmegen,","place":["the Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9828-9460","authenticated-orcid":false,"given":"Wouter J","family":"Plattel","sequence":"additional","affiliation":[{"name":"Department of Hematology, University Medical Centre Groningen , Groningen,","place":["the Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith M","family":"Roesink","sequence":"additional","affiliation":[{"name":"Department of Radiotherapy, University Medical Centre Utrecht , Utrecht,","place":["the Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2112-4443","authenticated-orcid":false,"given":"Karijn M S","family":"Verschueren","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Institute Verbeeten , Tilburg,","place":["the Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1074-5922","authenticated-orcid":false,"given":"Jos\u00e9e M","family":"Zijlstra","sequence":"additional","affiliation":[{"name":"Department of Hematology, Amsterdam University Medical Centre, location Vrije Universiteit, Cancer Centre Amsterdam , Amsterdam,","place":["the Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry R","family":"Koene","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, St. Antonius Hospital , Nieuwegein,","place":["the Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9069-4939","authenticated-orcid":false,"given":"Marten R","family":"Nijziel","sequence":"additional","affiliation":[{"name":"Catharina Cancer Institute, Department of Hemato-Oncology, Catharina Hospital , Eindhoven,","place":["the Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik C","family":"Schimmel","sequence":"additional","affiliation":[{"name":"Radiotherapiegroep Location Arnhem , Arnhem,","place":["the Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7416-5794","authenticated-orcid":false,"given":"Eva","family":"de Jongh","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Albert Schweitzer Hospital , Dordrecht,","place":["the Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-5793-6694","authenticated-orcid":false,"given":"Francisca","family":"Ong","sequence":"additional","affiliation":[{"name":"Department of Radiotherapy, Medisch Spectrum Twente , Enschede,","place":["the Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liane C J","family":"Te Boome","sequence":"additional","affiliation":[{"name":"Department of Hematology, Haaglanden Medical Centre , The Hague,","place":["the Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5608-706X","authenticated-orcid":false,"given":"Rozemarijn S","family":"van Rijn","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Medical Centre Leeuwarden , Leeuwarden,","place":["the Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1146-9309","authenticated-orcid":false,"given":"Lara H","family":"B\u00f6hmer","sequence":"additional","affiliation":[{"name":"Department of Hematology, Haga Teaching Hospital , The Hague,","place":["the Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5095-4652","authenticated-orcid":false,"given":"Bastiaan D P","family":"Ta","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology (MAASTRO), MAASTRO Clinic, GROW Research Institute for Oncology & Reproduction, Maastricht University Medical Centre+ , Maastricht,","place":["the Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hein P J","family":"Visser","sequence":"additional","affiliation":[{"name":"Department of Hematology, Noordwest Ziekenhuisgroep Alkmaar , Alkmaar,","place":["the Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0882-2346","authenticated-orcid":false,"given":"Eduardus F M","family":"Posthuma","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Reinier de Graaf Hospital , Delft,","place":["the Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3783-3407","authenticated-orcid":false,"given":"Yavuz M","family":"Bilgin","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, ADRZ , Goes,","place":["the Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-0137-2543","authenticated-orcid":false,"given":"Karin","family":"Muller","sequence":"additional","affiliation":[{"name":"Radiotherapiegroep Location Deventer , Deventer,","place":["the Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daphne","family":"van Kampen","sequence":"additional","affiliation":[{"name":"Zuidwest Radiotherapeutisch Instituut , Vlissingen,","place":["the Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan-Paul","family":"de Boer","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Netherlands Cancer Institute , Amsterdam,","place":["the Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4151-2865","authenticated-orcid":false,"given":"Cynthia","family":"So-Osman","sequence":"additional","affiliation":[{"name":"Department of Hematology, Erasmus Medical Centre , Rotterdam,","place":["the Netherlands"]},{"name":"Unit Transfusion Medicine, Sanquin Blood Supply Foundation , Amsterdam,","place":["the Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1628-6256","authenticated-orcid":false,"given":"Joost S P","family":"Vermaat","sequence":"additional","affiliation":[{"name":"Department of Hematology, Leiden University Medical Centre , Leiden,","place":["the Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1936-2437","authenticated-orcid":false,"given":"Roel J","family":"de Weijer","sequence":"additional","affiliation":[{"name":"Department of Hematology, University Medical Centre Utrecht , Utrecht,","place":["the Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8904-3802","authenticated-orcid":false,"given":"Marie Jos\u00e9","family":"Kersten","sequence":"additional","affiliation":[{"name":"Department of Hematology, Amsterdam University Medical Centre, Location University of Amsterdam, Cancer Centre Amsterdam and Lymphoma and Myeloma Expert Centre Amsterdam (LYMMCARE) , Amsterdam,","place":["the Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5871-1484","authenticated-orcid":false,"given":"Flora E","family":"van Leeuwen","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Netherlands Cancer Institute , Amsterdam,","place":["the Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5241-7105","authenticated-orcid":false,"given":"Yolande","family":"Appelman","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Amsterdam University Medical Centre Heart Centre, Amsterdam Cardiovascular Sciences, VU University , Amsterdam,","place":["the Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4390-7182","authenticated-orcid":false,"given":"Michael","family":"Schaapveld","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Netherlands Cancer Institute , Amsterdam,","place":["the Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,3,25]]},"reference":[{"key":"2026090719565121300_djag085-B1","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/S1470-2045(11)70235-2","article-title":"CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the MabThera International Trial (MInT) Group","volume":"12","author":"Pfreundschuh","year":"2011","journal-title":"Lancet Oncol"},{"key":"2026090719565121300_djag085-B2","author":"IKNL","year":"2019"},{"key":"2026090719565121300_djag085-B3","author":"Netherlands Cancer Registry (NCR), IKNL","year":"2023"},{"key":"2026090719565121300_djag085-B4","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1182\/blood-2006-07-034405","article-title":"Late cardiotoxicity after treatment for Hodgkin lymphoma","volume":"109","author":"Aleman","year":"2007","journal-title":"Blood"},{"key":"2026090719565121300_djag085-B5","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1001\/jamainternmed.2015.1180","article-title":"Cardiovascular disease after Hodgkin lymphoma treatment: 40-year disease risk","volume":"175","author":"van Nimwegen","year":"2015","journal-title":"JAMA Intern Med"},{"key":"2026090719565121300_djag085-B6","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1182\/blood-2016-09-740332","article-title":"Risk of heart failure in survivors of Hodgkin lymphoma: effects of cardiac exposure to radiation and anthracyclines","volume":"129","author":"van Nimwegen","year":"2017","journal-title":"Blood"},{"key":"2026090719565121300_djag085-B7","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1182\/asheducation-2016.1.323","article-title":"Long-term risk of second malignancy and cardiovascular disease after Hodgkin lymphoma treatment","volume":"2016","author":"van Leeuwen","year":"2016","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"2026090719565121300_djag085-B8","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1182\/blood-2005-08-3392","article-title":"Long-term risk of cardiovascular disease after treatment for aggressive non-Hodgkin lymphoma","volume":"107","author":"Moser","year":"2006","journal-title":"Blood"},{"key":"2026090719565121300_djag085-B9","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14010061","article-title":"Late cardiological sequelae and long-term monitoring in classical Hodgkin lymphoma and diffuse large B-cell lymphoma survivors: a systematic review by the Fondazione Italiana Linfomi","volume":"14","author":"Oliva","year":"2021","journal-title":"Cancers (Basel)"},{"key":"2026090719565121300_djag085-B10","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/bjh.15603","article-title":"Cumulative anthracycline exposure and risk of cardiotoxicity; a Danish nationwide cohort study of 2440 lymphoma patients treated with or without anthracyclines","volume":"183","author":"Baech","year":"2018","journal-title":"Br J Haematol"},{"key":"2026090719565121300_djag085-B11","doi-asserted-by":"crossref","first-page":"5107","DOI":"10.1182\/bloodadvances.2020002737","article-title":"Doxorubicin and subsequent risk of cardiovascular diseases among survivors of diffuse large B-cell lymphoma in Hong Kong","volume":"4","author":"Lee","year":"2020","journal-title":"Blood Adv"},{"key":"2026090719565121300_djag085-B12","first-page":"218","article-title":"Rituximab-induced polymorphic ventricular tachycardia","volume":"37","author":"Poterucha","year":"2010","journal-title":"Tex Heart Inst J"},{"key":"2026090719565121300_djag085-B13","first-page":"22","article-title":"A case of irreversible bradycardia after rituximab therapy for diffuse large B-cell lymphoma","volume":"6","author":"Ko Ko","year":"2020","journal-title":"Cardiooncology"},{"key":"2026090719565121300_djag085-B14","author":"World Health Organization","year":"2013"},{"key":"2026090719565121300_djag085-B15","doi-asserted-by":"crossref","first-page":"e103","DOI":"10.1111\/bjh.15936","article-title":"Setting up a national infrastructure for survivorship care after treatment for Hodgkin lymphoma","volume":"186","author":"Nijdam","year":"2019","journal-title":"Br J Haematol"},{"key":"2026090719565121300_djag085-B16","first-page":"A9269","article-title":"The BETER survivorship care initiative for Hodgkin lymphoma; tailored survivorship care for late effects of treatment","volume":"159","author":"Dekker","year":"2015","journal-title":"Nederlands Tijdschrift Voor Geneeskunde"},{"key":"2026090719565121300_djag085-B17","author":"World Health Organization","year":"2019"},{"key":"2026090719565121300_djag085-B18","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/tri.13081","article-title":"An unjustified benefit: immortal time bias in the analysis of time-dependent events","volume":"31","author":"Gleiss","year":"2018","journal-title":"Transpl Int"},{"key":"2026090719565121300_djag085-B19","author":"Gijsen","year":"2005"},{"key":"2026090719565121300_djag085-B20","author":"Nivel Research Communication Center","year":"2025"},{"key":"2026090719565121300_djag085-B21","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.0.CO;2-O","article-title":"Estimation of failure probabilities in the presence of competing risks: new representations of old estimators","volume":"18","author":"Gooley","year":"1999","journal-title":"Stat Med"},{"key":"2026090719565121300_djag085-B22","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.jaccao.2024.07.016","article-title":"Anthracycline cardiotoxicity in adult cancer patients: JACC: cardiooncology state-of-the-art review","volume":"6","author":"Camilli","year":"2024","journal-title":"JACC CardioOncol"},{"key":"2026090719565121300_djag085-B23","doi-asserted-by":"crossref","first-page":"3159","DOI":"10.1200\/JCO.2007.14.1242","article-title":"Doxorubicin, cardiac risk factors, and cardiac toxicity in elderly patients with diffuse B-cell non-Hodgkin\u2019s lymphoma","volume":"26","author":"Hershman","year":"2008","journal-title":"J Clin Oncol"},{"key":"2026090719565121300_djag085-B24","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1002\/jha2.1048","article-title":"Congestive heart failure after anthracycline-containing treatment for Hodgkin lymphoma: a Swedish matched cohort study","volume":"5","author":"Baech","year":"2024","journal-title":"EJHaem"},{"key":"2026090719565121300_djag085-B25","doi-asserted-by":"crossref","first-page":"3060","DOI":"10.1016\/S0021-9258(17)35746-0","article-title":"Redox cycling of anthracyclines by cardiac mitochondria. I. Anthracycline radical formation by NADH dehydrogenase","volume":"261","author":"Davies","year":"1986","journal-title":"J Biol Chem"},{"key":"2026090719565121300_djag085-B26","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1161\/CIRCULATIONAHA.114.013777","article-title":"Early detection of anthracycline cardiotoxicity and improvement with heart failure therapy","volume":"131","author":"Cardinale","year":"2015","journal-title":"Circulation"},{"key":"2026090719565121300_djag085-B27","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1038\/s41416-018-0159-x","article-title":"Cardiovascular disease incidence after internal mammary chain irradiation and anthracycline-based chemotherapy for breast cancer","volume":"119","author":"Boekel","year":"2018","journal-title":"Br J Cancer"},{"key":"2026090719565121300_djag085-B28","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.amjcard.2014.04.055","article-title":"Left ventricular function in long-term survivors of childhood lymphoma","volume":"114","author":"Christiansen","year":"2014","journal-title":"Am J Cardiol"},{"key":"2026090719565121300_djag085-B29","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1002\/pbc.22664","article-title":"Late valvular and other cardiac diseases after different doses of mediastinal radiotherapy for Hodgkin disease in children and adolescents: report from the longitudinal GPOH follow-up project of the German-Austrian DAL-HD studies","volume":"55","author":"Schellong","year":"2010","journal-title":"Pediatr Blood Cancer"},{"key":"2026090719565121300_djag085-B30","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1093\/jnci\/djp147","article-title":"Increased risk of stroke and transient ischemic attack in 5-year survivors of Hodgkin lymphoma","volume":"101","author":"De Bruin","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"2026090719565121300_djag085-B31","doi-asserted-by":"crossref","first-page":"3866","DOI":"10.21037\/jtd.2020.02.47","article-title":"Cardiovascular risk of smoking and benefits of smoking cessation","volume":"12","author":"Gallucci","year":"2020","journal-title":"J Thorac Dis"},{"key":"2026090719565121300_djag085-B32","doi-asserted-by":"crossref","first-page":"246","DOI":"10.5993\/AJHB.27.3.6","article-title":"Do adults change their lifestyle behaviors after a cancer diagnosis?","volume":"27","author":"Blanchard","year":"2003","journal-title":"Am J Health Behav"},{"key":"2026090719565121300_djag085-B33","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1002\/pbc.20421","article-title":"Health-risk behaviours among adolescent survivors of childhood cancer","volume":"45","author":"Bauld","year":"2005","journal-title":"Pediatr Blood Cancer"},{"key":"2026090719565121300_djag085-B34","author":"Federatie Medisch Specialisten"},{"key":"2026090719565121300_djag085-B35","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1001\/jama.2011.822","article-title":"Surveillance bias in outcomes reporting","volume":"305","author":"Haut","year":"2011","journal-title":"JAMA"},{"key":"2026090719565121300_djag085-B36","author":"Netherlands Comprehensive Cancer Organisation (IKNL","year":"2023"},{"key":"2026090719565121300_djag085-B37","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1182\/blood.V68.5.1114.1114","article-title":"Cyclophosphamide cardiotoxicity: an analysis of dosing as a risk factor","volume":"68","author":"Goldberg","year":"1986","journal-title":"Blood"},{"key":"2026090719565121300_djag085-B38","author":"Federatie Medisch Specialisten","year":"2016"},{"key":"2026090719565121300_djag085-B39","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1080\/10428194.2020.1842394","article-title":"A population-based study on different regimens of R-CHOP in patients with newly diagnosed DLBCL in The Netherlands","volume":"62","author":"Issa","year":"2021","journal-title":"Leuk Lymphoma"},{"key":"2026090719565121300_djag085-B40","first-page":"CD003917","article-title":"Cardioprotective interventions for cancer patients receiving anthracyclines","volume":"2","author":"van Dalen","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"2026090719565121300_djag085-B41","first-page":"8","article-title":"Rationale and design of the HOVON 170 DLBCL-ANTICIPATE trial: preventing anthracycline-induced cardiac dysfunction with dexrazoxane","volume":"11","author":"Linschoten","year":"2025","journal-title":"Cardiooncology"},{"key":"2026090719565121300_djag085-B42","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1186\/1471-2407-10-337","article-title":"Cardiotoxicity of anthracycline agents for the treatment of cancer: systematic review and meta-analysis of randomised controlled trials","volume":"10","author":"Smith","year":"2010","journal-title":"BMC Cancer"}],"container-title":["JNCI: Journal of the National Cancer Institute"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jnci\/advance-article-pdf\/doi\/10.1093\/jnci\/djag085\/67505886\/djag085.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jnci\/article-pdf\/118\/9\/1628\/67505886\/djag085.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jnci\/article-pdf\/118\/9\/1628\/67505886\/djag085.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T23:56:59Z","timestamp":1788825419000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jnci\/article\/118\/9\/1628\/8540043"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,25]]},"references-count":42,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,3,25]]},"published-print":{"date-parts":[[2026,9,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jnci\/djag085","relation":{},"ISSN":["0027-8874","1460-2105"],"issn-type":[{"value":"0027-8874","type":"print"},{"value":"1460-2105","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,9]]},"published":{"date-parts":[[2026,3,25]]}}}